Texas Health and Human Services
Blue Gradient

Summary of April 2023 Drug Utilization Review Board Meeting Now Available

The Texas Drug Utilization Review Board met Friday, April 28, to make recommendations about clinical prior authorizations and drugs on the Texas Medicaid Preferred Drug List.

Other news:


This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo